Homann HE - Search Results

1

Transient suppression of transgene expression by means of antisense oligonucleotides: a method for the production of toxin-transducing recombinant viruses.

Raykov Z, Legrand V, Homann HE, Rommelaere J. Raykov Z, et al. Among authors: homann he. Gene Ther. 2002 Mar;9(5):358-62. doi: 10.1038/sj.gt.3301660. Gene Ther. 2002. PMID: 11938456

2

Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.

Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X. Guo J, et al. Among authors: homann he. Gene Ther. 2002 Jun;9(12):793-803. doi: 10.1038/sj.gt.3301688. Gene Ther. 2002. PMID: 12040461

3

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach.

Régulier E, Paul S, Marigliano M, Kintz J, Poitevin Y, Ledoux C, Roecklin D, Cauet G, Calenda V, Homann HE. Régulier E, et al. Among authors: homann he. Cancer Gene Ther. 2001 Jan;8(1):45-54. doi: 10.1038/sj.cgt.7700278. Cancer Gene Ther. 2001. PMID: 11219493

4

Tumor gene therapy by MVA-mediated expression of T-cell-stimulating antibodies.

Paul S, Regulier E, Rooke R, Stoeckel F, Geist M, Homann H, Balloul JM, Villeval D, Poitevin Y, Kieny MP, Acres RB. Paul S, et al. Cancer Gene Ther. 2002 May;9(5):470-7. doi: 10.1038/sj.cgt.7700461. Cancer Gene Ther. 2002. PMID: 11961670

5

Cancer immunotherapy by direct in vivo transfer of immunomodulatory genes.

Leroy P, Slos P, Homann H, Erbs P, Poitevin Y, Regulier E, Colonna FQ, Devauchelle P, Roth C, Pavirani A, Mehtali M. Leroy P, et al. Res Immunol. 1998 Sep-Oct;149(7-8):681-4. doi: 10.1016/s0923-2494(99)80038-8. Res Immunol. 1998. PMID: 9851523 Review. No abstract available.

6

Gene transfer into canine myoblasts.

Braun S, Thioudellet C, Perraud F, Escriou C, Claudepierre MC, Homann H, Lusky M, Mehtali M, Bischoff R, Pavirani A. Braun S, et al. Cytotechnology. 1999 Jul;30(1-3):181-9. doi: 10.1023/A:1008026913715. Cytotechnology. 1999. PMID: 19003368 Free PMC article.

7

Sendai virus gene expression in lytically and persistently infected cells.

Homann HE, Hofschneider PH, Neubert WJ. Homann HE, et al. Virology. 1990 Jul;177(1):131-40. doi: 10.1016/0042-6822(90)90467-6. Virology. 1990. PMID: 1693801

8

The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation.

Curran J, Homann H, Buchholz C, Rochat S, Neubert W, Kolakofsky D. Curran J, et al. J Virol. 1993 Jul;67(7):4358-64. doi: 10.1128/JVI.67.7.4358-4364.1993. J Virol. 1993. PMID: 8389932 Free PMC article.

9

Sendai virus protein-protein interactions studied by a protein-blotting protein-overlay technique: mapping of domains on NP protein required for binding to P protein.

Homann HE, Willenbrink W, Buchholz CJ, Neubert WJ. Homann HE, et al. J Virol. 1991 Mar;65(3):1304-9. doi: 10.1128/JVI.65.3.1304-1309.1991. J Virol. 1991. PMID: 1847456 Free PMC article.

10

The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles.

Buchholz CJ, Retzler C, Homann HE, Neubert WJ. Buchholz CJ, et al. Among authors: homann he. Virology. 1994 Nov 1;204(2):770-6. doi: 10.1006/viro.1994.1592. Virology. 1994. PMID: 7941345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters